| Literature DB >> 26793340 |
Abstract
The widespread acceptance of left ventricular assist device (LVAD) implantation in the treatment of heart failure has revolutionized the way end stage heart failure is treated. Advances in LVAD technology combined with a better understanding of patient selection has led to unparalleled survival as well as a reduction in the adverse event profile of these pumps. As our understanding of heart failure continues to grow, there is little doubt that LVADs will continue to play a pivotal role as a therapeutic option for those suffering from heart failure.Entities:
Keywords: Left ventricular assist device (LVAD); mechanical circulatory support (MCS)
Year: 2015 PMID: 26793340 PMCID: PMC4703685 DOI: 10.3978/j.issn.2072-1439.2015.11.01
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895